甲状腺癌
甲状腺乳突癌
细胞生长
下调和上调
细胞周期蛋白D1
细胞周期
分子生物学
小RNA
转录因子
内科学
癌基因
Wnt信号通路
作者
Qiheng Gou,Linbo Gao,Xinwen Nie,Wenchen Pu,Jingqiang Zhu,Yichao Wang,Xuesha Liu,Shuangyan Tan,Jian-Kang Zhou,Yanqiu Gong,Juan He,Ke Wu,Yuxin Xie,Wanjun Zhao,Lunzhi Dai,Lunxu Liu,Rong Xiang,Yuquan Wei,Lin Zhang,Yong Peng
出处
期刊:Cancer Research
[American Association for Cancer Research]
日期:2018-08-01
卷期号:78 (15): 4163-4174
被引量:53
标识
DOI:10.1158/0008-5472.can-17-3766
摘要
Long noncoding RNAs (lncRNA) are emerging as a novel class of regulators in gene expression associated with tumorigenesis. However, the role of lncRNAs in papillary thyroid carcinoma (PTC) is poorly understood. Here, we conducted global lncRNA profiling and identified lncRNA AB074169 (lncAB) as significantly downregulated in PTC. Decreased expression of lncAB in PTC was caused by CpG hypermethylation within its gene promoter. Functional studies showed that lncAB overexpression led to cell-cycle arrest and tumor growth inhibition in vitro and in vivo, whereas lncAB knockdown promoted cell proliferation. Mechanistic analyses revealed that lncAB bound KH-type splicing regulatory protein (KHSRP) and also decreased expression of KHSRP, thus increasing CDKN1a (p21) expression and decreasing CDK2 expression to repress cell proliferation. Taken together, these findings demonstrate that lncAB functions as a tumor suppressor during PTC tumorigenesis.Significance: These findings identify a tumor-suppressive long noncoding RNA in papillary thyroid carcinoma.Graphical Abstract: http://cancerres.aacrjournals.org/content/canres/78/15/4163/F1.large.jpg Cancer Res; 78(15); 4163-74. ©2018 AACR.
科研通智能强力驱动
Strongly Powered by AbleSci AI